Evidence map›Paper›PMID 11175356›Full record

ReviewOncogene2000

Genetic analysis of ETS genes in C. elegans.

A H Hart, R Reventar, A Bernstein

Abstract readComparative StudyReview
PubMed Publisher
In one paragraph

Review in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The ETS-5 transcription factor regulates activity states inProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

A H HartProgram of Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1X5.
R Reventar
A Bernstein

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent completion of the Caenorhabditis elegans genome has revealed that this nematode worm has 10 members of the ETS gene family. Isolation and analysis of C. elegans mutants and subsequent screens to identify interacting genes can proceed very quickly in this model organism. Molecular genetic analysis of the receptor tyrosine kinase-Ras-MAP kinase signaling pathway in C. elegans identified the ETS family transcription factor Lin-1 as a nuclear effector of this evolutionarily conserved signal transduction pathway. Here we review classical genetic approaches used to discover the role of Lin-1 in the Ras-MAP kinase signaling pathway and describe new technologies that can be applied to the analyses of signaling pathways and transcription factor regulatory networks in C. elegans.

Indexed as

Caenorhabditis elegans ProteinsGenes, HelminthMultigene FamilyProto-Oncogene ProteinsAmino Acid SequenceAnimalsCaenorhabditis elegansCell LineageDimerizationDisorders of Sex DevelopmentDNA-Binding ProteinsEvolution, MolecularFemaleForecastingGene Expression ProfilingGene Expression RegulationCaenorhabditis elegans ProteinsDNA-Binding ProteinsERG protein, humanFli1 protein, mouseHelminth ProteinsLin-1 protein, C eleganslin-31 protein, C elegansOncogene ProteinsProteomeProto-Oncogene Protein c-fli-1Proto-Oncogene Proteinsras ProteinsReceptor Protein-Tyrosine KinasesTrans-ActivatorsTranscriptional Regulator ERGTranscription Factors

Identifiers

PMID11175356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.